|
JP6591532B2
(ja)
|
2014-08-21 |
2019-10-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
MDM2−p53阻害剤としての新しいスピロ[3H−インドール−3,2’−ピロリジン]−2(1H)−オン化合物および誘導体
|
|
CN108137484B
(zh)
*
|
2015-10-09 |
2021-02-12 |
西北大学 |
作为用于治疗癫痫、成瘾和肝细胞癌的gaba氨基转移酶灭活剂的化合物
|
|
HUE054985T2
(hu)
|
2015-10-09 |
2021-11-29 |
Boehringer Ingelheim Int |
Spiro[3H-indol-3,2'-pirrolidin]-2(1H)-on vegyületek és számrazékok, mint MDM2-P53 inhibitorok
|
|
KR20240110989A
(ko)
*
|
2017-02-08 |
2024-07-16 |
오비드 테라퓨틱스 인크. |
프라더-윌리 증후군 및 발작 장애들을 치료하는 방법들
|
|
US10653652B2
(en)
|
2018-02-08 |
2020-05-19 |
Ovid Therapeutics Inc. |
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
|
|
US11771671B2
(en)
|
2018-02-08 |
2023-10-03 |
Ovid Therapeutics Inc. |
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction
|
|
AU2019243586A1
(en)
*
|
2018-03-29 |
2020-10-15 |
Ovid Therapeutics Inc. |
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of eye disorders
|
|
US10822301B2
(en)
*
|
2018-04-12 |
2020-11-03 |
Northwestern University |
3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase
|
|
JP7475055B2
(ja)
|
2018-05-25 |
2024-04-26 |
ノースウェスタン ユニバーシティ |
(s)-3-アミノ-4-(ジフルオロメチレニル)シクロペンタ-1-エン-1-カルボン酸の合成法
|
|
WO2019236938A1
(en)
|
2018-06-07 |
2019-12-12 |
Ovid Therapeutics Inc. |
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
|
|
US11203596B2
(en)
|
2019-02-25 |
2021-12-21 |
Northwestern University |
Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity
|
|
US11078153B2
(en)
|
2019-04-03 |
2021-08-03 |
Northwestern University |
2-difluoro substituted 4-aminocyclopentanecarboxylic acids as inhibitors of gamma-aminobutyric acid aminotransferase and human ornithine aminotransferase
|
|
CN110935495B
(zh)
*
|
2019-11-29 |
2021-02-23 |
中国科学院电子学研究所 |
Gaba和电生理微纳同步传感检测芯片及其制备方法
|
|
US11993569B2
(en)
|
2020-01-23 |
2024-05-28 |
Northwestern University |
3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases
|
|
EP4301724A4
(en)
*
|
2021-03-03 |
2025-05-28 |
Northwestern University |
(S)-3-AMINO-4,4-DIHALOCYCLOPENT-1-CARBOXYLIC ACID AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE
|
|
US20250171397A1
(en)
*
|
2022-02-27 |
2025-05-29 |
Northwestern University |
(3s,4r)-3-amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic acid and related compounds as selective inactivators of ornithine aminotransferase
|
|
KR20250034134A
(ko)
*
|
2022-07-06 |
2025-03-10 |
오비드 테라퓨틱스 인크. |
암 치료에 있어서 (s)-3-아미노-4-(디플루오로메틸렌일)사이클로펜트-1-엔-1-카르복실산의 사용
|
|
KR20250145687A
(ko)
*
|
2023-02-17 |
2025-10-13 |
오비드 테라퓨틱스 인크. |
류마티스 관절염의 치료에 있어서 (s)-3-아미노-4-(디플루오로메틸레닐)사이클로펜트-1-엔-1-카르복시산의 용도
|
|
US20240285565A1
(en)
|
2023-02-17 |
2024-08-29 |
Ovid Therapeutics Inc. |
Use of (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of diabetes and pre-diabetes
|
|
AU2024220869A1
(en)
|
2023-02-17 |
2025-09-04 |
Ovid Therapeutics Inc. |
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid in the treatment of multiple sclerosis
|
|
IL322802A
(en)
|
2023-02-17 |
2025-10-01 |
Ovid Therapeutics Inc |
Use of (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of gastrointestinal disorders and as an immunomodulatory agent
|